apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain
- PMID: 19033669
- PMCID: PMC2582453
- DOI: 10.1172/JCI36663
apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain
Abstract
Neurotoxic amyloid beta peptide (Abeta) accumulates in the brains of individuals with Alzheimer disease (AD). The APOE4 allele is a major risk factor for sporadic AD and has been associated with increased brain parenchymal and vascular amyloid burden. How apoE isoforms influence Abeta accumulation in the brain has, however, remained unclear. Here, we have shown that apoE disrupts Abeta clearance across the mouse blood-brain barrier (BBB) in an isoform-specific manner (specifically, apoE4 had a greater disruptive effect than either apoE3 or apoE2). Abeta binding to apoE4 redirected the rapid clearance of free Abeta40/42 from the LDL receptor-related protein 1 (LRP1) to the VLDL receptor (VLDLR), which internalized apoE4 and Abeta-apoE4 complexes at the BBB more slowly than LRP1. In contrast, apoE2 and apoE3 as well as Abeta-apoE2 and Abeta-apoE3 complexes were cleared at the BBB via both VLDLR and LRP1 at a substantially faster rate than Abeta-apoE4 complexes. Astrocyte-secreted lipo-apoE2, lipo-apoE3, and lipo-apoE4 as well as their complexes with Abeta were cleared at the BBB by mechanisms similar to those of their respective lipid-poor isoforms but at 2- to 3-fold slower rates. Thus, apoE isoforms differentially regulate Abeta clearance from the brain, and this might contribute to the effects of APOE genotype on the disease process in both individuals with AD and animal models of AD.
Figures
Similar articles
-
Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.J Biol Chem. 2011 May 20;286(20):17536-42. doi: 10.1074/jbc.M111.225532. Epub 2011 Apr 6. J Biol Chem. 2011. PMID: 21471207 Free PMC article.
-
Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.Mol Neurodegener. 2018 Oct 19;13(1):57. doi: 10.1186/s13024-018-0286-0. Mol Neurodegener. 2018. PMID: 30340601 Free PMC article.
-
Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.Mol Neurodegener. 2015 Mar 5;10:6. doi: 10.1186/s13024-015-0001-3. Mol Neurodegener. 2015. PMID: 25871773 Free PMC article.
-
The interaction of amyloid-beta with ApoE.Subcell Biochem. 2005;38:255-72. doi: 10.1007/0-387-23226-5_13. Subcell Biochem. 2005. PMID: 15709483 Review.
-
Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.Mol Neurodegener. 2014 Jan 4;9:2. doi: 10.1186/1750-1326-9-2. Mol Neurodegener. 2014. PMID: 24386905 Free PMC article. Review.
Cited by 263 articles
-
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA): Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease-Opportunities for Therapy.Alzheimers Dement (Amst). 2020 Aug 3;12(1):e12053. doi: 10.1002/dad2.12053. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 32775596 Free PMC article.
-
Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes.Int J Mol Sci. 2020 Jul 21;21(14):5149. doi: 10.3390/ijms21145149. Int J Mol Sci. 2020. PMID: 32708198 Free PMC article. Review.
-
The Positive Side of the Alzheimer's Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1.Molecules. 2020 May 23;25(10):2439. doi: 10.3390/molecules25102439. Molecules. 2020. PMID: 32456156 Free PMC article. Review.
-
[Gene-specific treatment approaches in Alzheimer's disease and other tauopathies].Nervenarzt. 2020 Apr;91(4):312-317. doi: 10.1007/s00115-020-00872-6. Nervenarzt. 2020. PMID: 32076757 Review. German.
-
Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk.Neurobiol Dis. 2020 May;138:104788. doi: 10.1016/j.nbd.2020.104788. Epub 2020 Feb 5. Neurobiol Dis. 2020. PMID: 32032733 Review.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Molecular Biology Databases
-
Research Materials
-
Miscellaneous